Antifungal stewardship: towards defining safe stopping criteria for therapeutic oral azoles.
UCL Cancer Institute, University College London, London, UK. m.marzolini@ucl.ac.uk.
Maria A V
MA
Marzolini
UCL Cancer Institute, University College London, London, UK.
Kirsty J
KJ
Thomson
UCL Cancer Institute, University College London, London, UK.
Karl S
KS
Peggs
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000465:Algorithms; D000935:Antifungal Agents / Q000008:administration & dosage*; D001393:Azoles / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D016903:Drug Monitoring / Q000379:methods; D006801:Humans; D008875:Middle Aged; D009181:Mycoses / Q000188:drug therapy*; D028761:Withholding Treatment; D055815:Young Adult
D000935:Antifungal Agents; D001393:Azoles
antifungal; chemotherapy; fungal infection; therapy; transplant